New depression drug enters Mid-Stage human testing
Disease control
Recruiting now
This study is testing an experimental drug called GM-2505 for people with major depressive disorder. Researchers want to see if it's safe and if it shows early signs of helping with depression symptoms. The trial has three parts: testing the drug alone in some patients, testing i…
Phase: PHASE2 • Sponsor: Gilgamesh Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC